Sign in

CIK 0001563880

  • Non-accelerated filer
  • Smaller reporting company

Trevi Therapeutics, Inc.

Sign in to watch
Ticker
TRVI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
450834299
Phone
+1 203-304-2499
Business address
195 CHURCH STREET, 16TH FLOOR, NEW HAVEN, CT, 06510
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$595,806
in 1 filing, $596K under 10b5-1 plans

Net −$595,806. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Heffernan Michael Thomas −$596K Director sold 86% of stake

Reading 6 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-03 Colangelo Dominick Director Grant or award · Nonstatutory Stock Option (right to buy) +35,000 35,000
2025-06-11 Colangelo Dominick Director Grant or award · Nonstatutory Stock Option (right to buy) +45,000 45,000
2024-06-13 Colangelo Dominick Director Grant or award · Nonstatutory Stock Option (right to buy) +30,000 30,000
2023-06-28 Colangelo Dominick Director Grant or award · Nonstatutory Stock Option (right to buy) +30,000 30,000
2022-06-23 Colangelo Dominick Director Grant or award · Nonstatutory Stock Option (right to buy) +20,000 20,000
2022-06-23 Colangelo Dominick Director Grant or award · Nonstatutory Stock Option (right to buy) +20,000 20,000
2021-06-16 Colangelo Dominick Director Grant or award · Nonstatutory Stock Option (right to buy) +20,000 20,000
2020-06-29 Colangelo Dominick Director Grant or award · Nonstatutory Stock Option (right to buy) +23,684 23,684

Page 1 of 1 · 8 trades